Abstract. Breast cancer is a leading cause of mortality in women. In Malaysia, it is the most common cancer to affect women. The most common form of breast cancer is infiltrating ductal carcinoma (IDC). A proteomic approach was undertaken to identify protein profile changes between cancerous and normal breast tissues from 18 patients. Two protein extracts; aqueous soluble and membrane associated protein extracts were studied. Thirty four differentially expressed proteins were identified. The intensities of the proteins were used as variables in PCA and reduced data of six principal components (PC) were subjected to LDA in order to evaluate the potential of these proteins as collective biomarkers for breast cancer. The protein intensities of SEC13-like 1 (isoform b) and calreticulin contributed the most to the first PC while the protein intensities of fibrinogen beta chain precursor and ATP synthase D chain contributed the most to the second PC. Transthyretin precursor and apolipoprotein A-1 precursor contributed the most to the third PC. The results of LDA indicated good classification of samples into normal and cancerous types when the first 6 PCs were used as the variables. 
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Introduction
Breast cancer is one of the major causes of death worldwide. It is responsible for 519 000 deaths around the world each year [1] . Breast cancer is the most common cancer affecting women, comprising 16% of all female cancer cases [2] . In Malaysia, breast cancer is the leading form of cancer in all ethnic and age groups for women and 1 in 19 women will have the disease in their lifetime [3] . Invasive ductal carcinoma is the most common form of invasive breast cancer, accounting for 85% of all breast cancer cases [4] .
Proteomics is the study of the proteome, which is the entire complement of proteins expressed by an organism [5] . Proteomics approach has been used to identify protein biomarkers in breast cancer [6] [7] [8] [9] [10] [11] and other types of cancers [12] [13] [14] [15] . The functional roles of these biomarkers in cancers may have important prognostic values in the detection and treatment of cancers [16, 17] .
Principal component analysis (PCA) is a statistical test that analyzes multivariate data by reducing the number of variables for data analysis and interpretation [18] . PCA reduces the dimensionality of a multivariate data while retaining the most of the variance in the data. Linear discriminant analysis (LDA) is a technique to separate observations into several groups or categories [19] . The aim of LDA is to classify samples and identify variables that give optimum discrimination between the groups of test subjects. PCA has been used to analyze and reduce the dimensionality of proteome data in various experimental models [20] [21] [22] [23] , and together with LDA, they have been used to generate tumor classification models based on protein profile patterns in cancer [21] .
In this study, we applied PCA and LDA on the differentially expressed aqueous soluble and membrane associated proteins between normal and cancerous breast tissues from breast cancer patients in Malaysia. The significance of these differentially expressed proteins as collective biomarkers for infiltrating ductal carcinoma among Malaysian female breast cancer was evaluated.
Methods and materials
Breast cancer patients
Eighteen breast cancer patients were included in the study. The patients were diagnosed with the disease for the first time and had not received breast cancer pretreatment. All patients were diagnosed with infiltrating ductal carcinoma (IDC) and had undergone surgery at Penang Hospital, Malaysia. Human ethical clearance for conducting this study was approved by the human ethical committee of Ministry of Health Malaysia and human ethical committee of Universiti Sains Malaysia, Malaysia. Informed consents were obtained from the patients before the tissues were collected for analysis. The information regarding patients is shown in Table 1 .
Tissue collection
Tissue specimens of both normal and cancerous breast were collected at the Penang Hospital, Malaysia. In all cases, the normal breast tissues taken were adjacent to the cancerous parts. The tissue pathology was confirmed by the hospital's pathologist. Frozen sections of cancer tissue were taken from tissues in the anterior and deep region. Only cancerous tissues that contained greater than 90% malignant cells were used in this study. The breast tissues were stored at −80
• C prior to analysis.
Protein extraction
Frozen breast tissues were thawed, rinsed with distiller water and cut into small pieces. Sequential extraction of aqueous soluble proteins and membrane associated proteins was performed based on the method by Molloy et al. [24] . Two volumes of TRIS buffer (40 mM Tris, 1 mM AEBSF) were added to the tissues, which were homogenized in order to extract aqueous soluble proteins. The supernatant was recovered after centrifugation (13 000 rpm, 15 min, 20
• C). The pellet was washed 3 times with 1 volume of TRIS buffer each before 1 volume of thiourea lysis buffer (TLB) [8 M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.4% (w/v) carrier ampholytes, 50 mM DTT] was added to extract membrane associated proteins. The mixture was vortexed and the supernatant was recovered after centrifugation (13 000 rpm, 15 min, 20
• C). The protein concentrations for both TRIS and TLB extracts were determined using RC-DC protein assay (Bio-Rad, USA). The aqueous soluble protein in TRIS extract was precipitated and concentrated using trichloroacetic acid (TCA) / acetone precipitation. The TRIS extract was incubated in 10% (w/v) TCA in ice-cold acetone containing 20 mM DTT at −20
• C for 1.5 hours. After centrifugation (13 000 rpm, 15 min, 4
• C) the supernatant was discarded. The pellet was washed in ice-cold acetone containing 20 mM DTT and centrifuged (13 000 rpm, 15 min, 4
• C). After discarding the supernatant, the pellet was incubated in TLB for 1 hour to resolubilize the proteins. Each tissue samples was analyzed in duplicates.
2D-PAGE
Protein extract containing 250 µg of protein was rehydrated into an 11 cm, pH 4-7 IPG strip (Bio-Rad, USA) for 15 hours at 20
• C. Isoelectric focusing (IEF) was performed in a Protean IEF Cell (Bio-Rad, USA) at 20
• C for 15 min at 250 V, 2.5 hours at 8000 V and sustained at 8000 V for 30000 V-hours. After IEF, the focused IPG strip was incubated in equilibration buffer I [6M Urea, 0.375M Tris-HCl, pH 8. 
Gel imaging and analysis
Gel images were photographed using a Versadoc system (Bio-Rad, USA). The digitized gel images were processed using PDQuest software version 7.3 (BioRad, USA). The software used the images to create a matchset to compare and match protein spots in every normal and cancerous breast tissues. Each protein spots was normalized as a percentage of the total density of each gel for quantitative purposes. A protein is up-regulated if its expression level in cancerous tissues is elevated by 1.5-fold or more as compared to normal breast tissue and was down-regulated when its expression level in the cancerous tissues was reduced by 1.5-fold or more as compared to the normal breast tissue. The statistical significance of the changes in protein expression was analyzed by the Wilcoxon-signed rank test in PDQuest.
In-gel digestion and LC-MS/MS analysis
In-gel digestion of protein spots was performed using the method by Othman et al. [25] Protein spots of interest were cut from the gel, washed with 100 mM ammonium bicarbonate (NH 4 HCO 3 ) and dehydrated with acetonitrile (ACN). The protein was reduced and alkylated with incubating with DTT and iodoacetamide in 100 mM NH 4 HCO 3 respectively. Trypsin was added to digest the proteins. The tryptic peptides were eluted from the gel pieces and dehydrated under constant flow of nitrogen gas. Thirty microlitres of 0.1% (v/v) formic acid in 85:15 solution of deionized water:acetonitrile were added to reconstitute the peptides and these were fractionated by RP-HPLC (C18, 150 X 0.3 mm, 5 µm 300Å) using an Agilent 1100 Series. The mobile phases A [0.1% (v/v) formic acid in deionized water] and B [0.1% (v/v) formic acid in ACN] were pumped at a constant flow rate of 4 µL/min. The peptides were eluted by linear gradient of 5% to 95% mobile phase B in 70 minutes and sustained at 95% mobile phase B for 5 min. The RP-HPLC was interfaced to an ESIion trap mass analyzer (Agilent). The two most intense ions in an MS scan that exceeded the set threshold (5000 counts) were isolated for MS/MS scans to produce series of product ions spectra for protein identification. The instrumental parameters used were: nebulizer pressure at 20 psi, auxiliary dry gas flow of 6 L/min, auxiliary dry gas temperature at 300
• C, capillary voltage at 3. a scan time 1 s and an interscan time of 0.1 s were used. The parameters for MS/MS scan were: default collision energy (voltage) of 1.15V, charge state of 2, minimum threshold of 5000 counts, and isolation width of 2 m/z. Protein identification was done by subjecting the MS/MS data to a MASCOT (version 2.2) search using the MASCOT database search engine (MSDB), available at http://www.matrixscience.com. The search parameters used were: Homo sapiens for taxonomy, carboxymethyl for fixed modifications, peptide tolerance of ± 2 Da, MS/MS tolerance of ± 0.8 Da, average experimental mass value, one allowed miscleavage and unrestricted protein mass.
Western blot
Western blot was performed using the semi-dry method by Lauriere [26] . Proteins were separated by one-dimensional SDS-PAGE and incubated in cold transfer buffer (25 mM Tris, 192 mM glycine, 1.3 mM SDS, pH 8.3). Similar quantities of protein were transferred to a nitrocellulose membrane at 134 mA for 1.5 hours using a TE 70 Semiphor semi-dry transfer unit (Hoefer Scientific, Germany). The membrane was incubated with blocking buffer [3% (w/v) bovine serum albumin (BSA) in phosphate buffered saline (PBS), pH 7.2] for 2 hours at room temperature. The membrane was washed with washing buffer [0.1% (w/v) BSA, 0.1% (v/v) Tween 20 in PBS] and incubated in 20 mL of mouse anti-calreticulin monoclonal antibody (Abnova, Taiwan) with 1:1000 dilution in antibody diluent buffer [0.1% (w/v) BSA, 0.1% Tween 20, 0.02% sodium azide in PBS] overnight at room temperature. After washing, the membrane was incubated in 30 mL of horseradish peroxidase (HRP) conjugated anti-mouse secondary antibody (Bio-Rad, USA) at 1:3000 dilution for 2 hours at room temperature. The membrane was then washed and after washing, the membrane was incubated in 20mL of 4-Chloro naphthol (4CN) substrate solution (Bio-Rad, USA) to visualize the protein band.
PCA and LDA
The protein spot intensities analyzed using PDQuest were imported to Statistical Package for Social Science (SPSS) version 15. SPSS was used to perform PCA based on protein spot intensities as variables. The PCs obtained from PCA were analyzed as variables in LDA using SPSS. Figure 1 shows the 2D gel images of Tris extracts of cancerous and normal tissues, while Fig. 2 shows the images of TLB extracts of the tissues. Figure 3a and b show the examples of spot intensities of 14-3-3 protein zeta and calreticulin extracted from 2D gel images in Tris and TLB buffer, respectively. The bar charts indicate the expression levels of the two proteins in normal and cancerous breast tissues. The differences in spots intensity of the same protein indicated that these proteins were differentially expressed between cancerous and normal tissues. Table 2 lists the proteins identified in this study. The proteins' grand average of hydropathy (GRAVY) score indicates the hydrophilicity of the proteins, whereby the more negative the score, the higher is the hydrophilic property. Although most of the proteins identified were up-regulated proteins in cancerous tissues, the expression levels of the same protein varied amongst patients in both cancerous and normal tissues. The total fold change referred to the relative accumulated intensity of the proteins between cancerous and normal tissues from all the patients, where the positive sign indicated greater total intensity of the protein was identified in cancerous tissues while negative sign indicated greater total protein intensity was detected in the normal tissues. Figure 4a shows the Western blot of calreticulin in both normal and cancerous protein extracts from two patients. The up-regulation of calreticulin was confirmed by the Western blot result. Figure 4b shows the Western blot result for beta-actin in normal and cancerous tissues, where the expression levels of beta-actin was found relatively similar between the two tissues. Beta-actin is used as a positive control in this study. The statistical significance of the changes in expression levels of these proteins was further tested using the Wilcoxon signed-rank test. The differential expressions of the proteins identified in this study were statistically significant at a 95% confidence level (p < 0.05). Figure 5 shows the percentage of up-regulation, equal expression, down-regulation and non-expression of the proteins in all patients. Principal component analysis was performed on the normalized protein spot intensities for all the 34 protein spots identified. The number of variables was reduced to 10 PCs based on eigenvalues above one [27] and the first 6 PCs were used as variables in LDA. The first PC accounted for 28.12% of the total data variance, the second PC accounted 12.45% and the third PC 8.32%. The fourth, fifth and sixth contributed respectively 7.76, 6.29 and 5.52% of the total variance. Overall, these 6 PC accounted for 68.46% of the total data variance.
Results
The protein intensities of SEC13-like 1 (isoform b) and calreticulin contributed the most to the first PC while the protein intensities of fibrinogen beta chain precursor and ATP synthase D chain contributed the most to the second PC. Transthyretin precursor and apolipoprotein A-1 precursor contributed the most to the third PC. The protein intensities of SEC13-like 1 (isoform b) and calreticulin were the parameters that provide maximum discrimination between normal and cancerous breast specimens. Often, the first few PCs are associated with structure in the data or in this case differentiation between diseases states whereas the other PCs are associated with random variation [28] . The three-dimensional plot of the PCA is shown in Fig. 6 , where the x-, y-, and z-axis were defined by the first, second and third PCs. The observations were separated into two regions.
The results of LDA using 6 PCs are shown in Table 3 . The results indicated good classification of samples into normal and cancerous types when the first 6 PCs were used as the variables. Of all the original grouped samples, 91.7% were correctly classified while 88.9% of the cross-validated samples were correctly classified. In cross-validation, each sample is classified based on the characteristics of all the other remaining samples present.
Discussion
Normal and cancerous breast tissues obtained from human patients were used in the analyses, therefore, data obtained in this study represents the actual changes in protein expression between normal and cancerous tissues of infiltrating ductal carcinoma (IDC). Comparison was carried out in a pair-wise basis, where the pair of normal and cancerous tissues was obtained from the same patients. In the absence of laser capture microdissection [29] , which is normally used for isolating specific cells of interest from microscopic regions of tissue by cutting the tissues directly with an ultraviolet pulsed laser, the potential biomarkers were identified through the determination of consistently differential expressed protein by cross-comparison between tissues from all the 18 patients tested. By using this approach, we minimized the possibility of identification of false proteins that were not related to IDC and at the same time, both epithelial-derived and stromal-derived proteins were extracted, where stromal-derived proteins was recently suggested potentially serve as biomarkers of cancers [30] .
The patients involved in this study were all afflicted with IDC and the selection was done without considering race, cancer stage, grade or the status of the receptors. There is no single protein detected as unique in either normal or cancerous breast tissue and there is also no single protein that was consistently (100%) up-regulated or down-regulated in cancerous or normal tissues, respectively. Due to tissues heterogeneity, the intensities of the proteins varied greatly between the patients although consistent expression levels (upregulation and down-regulation) of the proteins can be detected in patients. Therefore, it is not possible to predict the state of IDC by referring only to one protein.
All the 34 differentially expressed proteins identified were subjected to PCA and the reduced data was used for LDA in order to determine the usability of these proteins for indicating the state of IDC. Our PCA and LDA had shown that the expression of six proteins out of the 34 proteins identified can be used reliably to predict the state of IDC, five of the proteins were up-regulated proteins; SEC13-like 1 (isoform b), calreticulin, ATP synthase D chain, Transthyretin precursor, apolipoprotein A-1 precursor. The only down regulated protein identified in this study capable of predicting IDC was fibrinogen beta chain precursor.
The original 34 variables (refer to the intensity of potential proteins identified) were reduced to 6 PCs that accounted for 68.46% of the total data variance, and these PCs were shown to be sufficient to indicate the state of cancer. This is shown by the subsequent LDA analysis which calculated that 91.7% of the originally grouped normal and cancerous tissues were correctly classified while 88.9% of the cross-validated samples were correctly classified. This approach is used as LDA is sensitive to the ratio of sample size which is the number of observations to the number of variables. In general, five observations are recommended for each variable [31] . Moreover, using this approach, the parameters that are responsible for differentiation can be easily identified as they are the ones that contribute most to the reduced PCs. It is also noticed that 3 PCs are quite sufficient to show groupings as most of the breast normal or cancerous tissues are correctly grouped into defined regions in the PCA plot except for a few tissues that were not grouped correctly. This discrepancy could be caused by errors in sampling, variations in experimental conditions and individual patient variation.
Calreticulin is one of the two major proteins that contribute to the significance of PCA. There have been some previous reports on the up-regulation of this protein in cancers [32] [33] [34] [35] and it had been marked as a marker for diagnosis of bladder cancer [36] . High expression of calreticulin in cancer has been suggested to prevent tumor cell lysis by stabilizing the cell membrane [37] [38] [39] . Calreticulin was detected in both Tris and TLB buffer extracts as up-regulated proteins in this study.
Protein SEC13 homolog (SEC13) is another major protein that contributes greatly to the PCA for discrimination of normal and cancerous breast tissues. SEC13 has not been reported previously for its involvement in cancer. It is a mammalian protein, which belongs to the SEC13 family of WD-repeat proteins. It is required for vesicle biogenesis from the endoplasmic reticulum during the transport of proteins [40] via budding of vesicles from the endoplasmic reticulum to form the Golgi apparatus [41] .
The mitochondrial adenosine triphosphate synthase (ATPS), delta subunit is a subunit of the hydrolase enzyme ATPS that involve in synthesis of ATP for energy consumption of cells. ATPS is therefore crucial to the survival of cells. Down-regulation of ATP synthase beta subunit was reported in various types of cancer, including breast cancer [42, 43] , which was suggested to cause impairment of oxidative metabolism and therefore induce malignant cell growth [44, 45] . In addition, inhibition of ATPS activity has been shown to inhibit the proliferation of several breast cancer cell lines by inducing apoptosis and arresting cell cycle [46] [47] [48] . In this study, ATPS was found up-regulated in cancerous tissues, and our finding is in agreement with Huang et al. [48] .
Apolipoprotein A-1 (ApoA-1) is part of lipidbinding proteins family that constitutes the plasma lipoproteins. ApoA-1 precursor was found to be significantly over-expressed in IDC cells compared to normal breast cells [49] . The level of ApoA-1 in sera may hold a prognostic value in the individuals with high-risk breast cancer [50] . ApoA-1 is the major protein component of high density lipoprotein (HDL) that acts as a cofactor for the enzyme lecithin chlosterolacyltransferase (LCAT), which is responsible for the formation of plasma cholesteryl ester. In addition, it is involved in the transportation of cholesterol from tissues and arteries to the liver for excretion.
Transthyretin (TTR) or pre-albumin is carrier protein in serum that carries thyroid hormone thyroxine (T4), retinol or Vitamin A. In addition, TTR was thought to sweep up toxic and foreign compounds in the blood stream. The increased levels of TTR are being used as a biomarker for the detection of colorectal carcinoma [51] . In contrary, TTR levels have been shown to decrease in patients with pancreatic cancer [52] .
Fibrinogen beta chain (FBB) is the beta component of the fibrinogen glycoprotein, Following injury, fibrinogen is cleaved by the thrombin enzyme to form fibrin, which is the principal protein involved in the clotting of blood. FBB fragments were identified in various solid types and may indicate cancer-related fibrin deposition [53, 54] . The deposition of fibrin and fibrinogen into the extracellular matrix (ECM) of tumors serves to support the binding of growth factors and to promote the responses of cell proliferation, migration and adhesion during angiogenesis and tumor cell growth [55] [56] [57] and increase metastatic potential of circulating tumor cells [58] . In contrast, Chahed et al. [49] have reported that a particular type of fibrin and fibrinogen fragments that display anti-angiogenic effect was detected as down regulated protein in IDC. Fibrinogen was detected as a down-regulated protein with greater abundance of expression in the normal tissue as compared with the cancerous tissues, and its down-regulation features have shown to contribute to the identification of cancerous tissues.
Conclusion
The patients involved in this study comprised of combination of Chinese, Indian and Malay whom were diagnosed with different stages, grades of IDC breast cancer, and with the combination of different receptors, the LDA indicated that the classification of cancerous and normal tissues by collective used of the biomarkers can be performed at high accuracy levels regardless of grade, stage and receptors status of the tissues, and race of the patients. PCA of the whole data set reduced the data to ten PCs of which six PCs gave reliable discrimination of the cancerous and normal tissue. Six proteins that showed high standard deviations between patients had high contributions to the first three PCs and these proteins were associated with discrimination of both diseased and non-diseased samples. We see the possibility of using this similar approach in prediction the prognosis of the disease, which we will study in the near future.
